Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia

Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia provides urologists of all levels with a practical, highly clinical guide to the variety of different symptoms and problems concerning the male lower urinary tract, including benign prostatic hyperplasia, one of the conditions that urologists most regularly encounter.  

Evidence-based throughout and written by the world's leading experts in the topic, it comprehensively reviews the very latest in diagnostics and imaging, patient phenotyping, genetic studies, medical and surgical therapies, and lifestyle management in order to help clinicians best manage their patients.

Highlights include chapters on: 

• Alpha-Adrenergic Antagonists for Lower Urinary Symptoms Secondary to Benign Prostatic Hyperplasia
• Phosphodiesterase Type 5 inhibitors for Male LUTS
• Combination Medical Therapy for Male LUTS
• Open Simple Prostatectomy
• Minimally Invasive Therapies
• Monopolar and Bipolar Transurethral Resection of the Prostate
• GreenLight Laser Therapy

Containing pitfall boxes and key points throughout to aid quick and easy understanding of the key information, this excellent book is an essential read for the modern-day urologist.

Contributors, vii

1 Etiology and Pathogenesis, 1
Robert H. Getzenberg & Prakash Kulkarni

2 Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: Epidemiology, Correlates, and Risk Factors, 10
Raymond C. Rosen & Benjamin N. Breyer

3 Clinical Assessment and Diagnosis of Lower Urinary Tract Dysfunction: United States, 22
Christopher P. Filson & John T. Wei

4 Clinical Assessment and Diagnosis of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Europe, 37
Stavros Gravas & Jean J. M. C. H. de la Rosette

5 Clinical Assessment and Diagnosis of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Primary Care, 47
Matt T. Rosenberg, John B. Riley & Marty M. Miner

6 Watchful Waiting, 59
Reginald Bruskewitz

7 α-Adrenergic Antagonists for Lower Urinary Symptoms Secondary to Benign Prostatic Hyperplasia, 70
Nathaly François, Raunak D. Patel & Kevin T. McVary

8 5α-Reductase Inhibitors, 90
Claudius Füllhase & Roberto Soler

9 Antimuscarinics, 100
Nadir I. Osman & Christopher R. Chapple

10 The Use of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia, 113
Casey Lythgoe & Kevin T. McVary

11 Combination Medical Therapy for Male Lower Urinary Tract Symptoms, 129
Claus G. Roehrborn

12 Complementary Therapy, 154
Aaron E. Katz & Anne Darves-Bornoz

13 Open Simple Prostatectomy, 164
Annika Herlemann, Matthias Oelke & Christian Gratzke

14 Minimally Invasive Therapies, 175
Mauro Gacci, Matteo Salvi and Arcangelo Sebastianelli

15 Holmium Laser Prostatectomy, 184
Simon van Rij & Peter J. Gilling

16 Benign Prostatic Hyperplasia: GreenLight Laser Therapy, 191
Alexis E. Te & Bilal Chughtai

17 Principles of Electrocautery-Based Techniques, 201
Aaron M. Bernie & Richard Lee

Index, 211

Steven A. Kaplan, MD, E. Darracott Vaughan Jr. Professor of Urology, Director, Iris Cantor Men's Health Center, New York Presbyterian Hospital, New York, NY, USA
Dr. Kaplan has had over 725 articles and 170 abstracts published and has made over 300 presentations in more than 35 countries. He is the author of two books and is on the Editorial Board of Urology, Journal of Urology, Wiley's BJUI and Urology Times. A member of more than 30 professional organizations, he is also a member of the WHO Committee on treating BPH, has been awarded 5 NIH grants and has received over 13 million dollars in research funding. He was awarded the John K. Lattimer Award for Lifetime Achievement in Urology by the National Kidney Foundation.

Kevin T. McVary, MD, FACS, Professor and Chair, Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, USA
Dr. McVary is Chairman of both the AUA BPH Clinical Guidelines Committee and the Special Emphasis Urology Study Section for the NIDDK. He is Co-Chairman of the Clinical Section of the NIDDK Strategic Pathway for Prostate Basic and Clinical Science, and the AUA Honorary Speaker at the European Association of Urology (EAU). Dr. McVary has been principal investigator for more than 75 clinical trials and his research has generated more than 120 publications including journal articles, book chapters, and abstracts. His work has appeared in prominent journals such as the Journal of Urology, Journal of the American Medical Association (JAMA), New England Journal of Medicine, International Journal of Impotence Research, and Urology. He is an editorial consultant for the Journal of Andrology, Journal of Urology, Urology, Journal of Investigative Urology, Current Opinion in Urology, and Prostate Diseases.